POST-ACUTE COVID-19

Clinical trials for POST-ACUTE COVID-19 explained in plain language.

Never miss a new study

Get alerted when new POST-ACUTE COVID-19 trials appear

Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Could an arthritis drug ease long COVID lung woes?

Disease control Recruiting now

This study tests a drug called anakinra (already used for arthritis) in 182 adults with long COVID who have ongoing breathing issues and signs of an overactive immune system. Participants receive either anakinra or a placebo for 4 to 8 weeks. The goal is to see if the drug can im…

Matched conditions: POST-ACUTE COVID-19

Phase: PHASE2, PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control

Last updated May 13, 2026 15:59 UTC

POST-ACUTE COVID-19

Get alerted when new POST-ACUTE COVID-19 trials appear

Could an arthritis drug ease long COVID lung woes?